Homology Medicines Announces FDA Fast Track Designation for HMI-102 Gene Therapy Development Candidate for Adults with PKU


You May Also Like

Viracta Announces Scientific Advisory Board Formation

SAN DIEGO, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc., a clinical-stage drug ...

Accelerate Diagnostics to Present Data at European Congress

TUCSON, Ariz., April 10, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (“Accelerate”) announced today ...